Expression of the pro-apoptotic tumor suppressor Bax can be silenced by frameshift mutations in its microsatellite coding region, leading to a Bax-negative phenotype. Such Bax mutations occur in ~50% of hereditary nonpolyposis colorectal cancer (HNPCC) due to deficiency of mismatch repair system associated microsatellite instability (MSI). Loss of Bax has been demonstrated to increase chemoresistance and is associated with poor prognosis. Recently, we found that some Bax-negative tumor cells actually contain a functional Bax isoform, Bax?2, which is generated when alternative splicing corrects the mutation-induced frameshift. Therefore, Bax?2 only exists in microsatellite-mutated cells. We have demonstrated that this salvaged Bax?2 is pro-death, similar to prototype Bax, but induce cell death potential through a non- mitochondrial death pathway. Importantly, colon cancer cells expressing Bax?2 are more sensitive to selected chemotherapeutics. Therefore, we hypothesize that Bax?2 determines tumor malignant potential and chemotherapeutic selectivity in Bax-negative MSI colorectal cancer cells through a non-canonical Bax- death pathway. We have two specific aims: 1) to study the mechanism underlying Bax?2-mediated cell death; and 2) to identify key regulators responsible for controlling Bax?2 expression levels in MSI colorectal tumor cells. Since there was no awareness of the existence of a Bax isoform in the Bax-negative cancer prior to this study, we think the studies proposed in this grant application are conceptually innovative and significant because they will change the current paradigm for understanding the development and prognosis of the Bax-negative MSI colorectal cancer and facilitating selection of specific chemotherapeutics for this subgroup of Bax-negative colon cancer patients. The Illinois Institute of Technology (IIT) is a private university with a wide range of academic disciplines. The University encourages biological research and promotes integrative biomedical research with potential translational impact. IIT currently lacks several biomedical facilities, such as high-level genomic and imaging facilities, a full-featured animal facility, and clinical resources. However, IIT does have a large body of undergraduate and graduate students eager to participate in biomedical research. The PI has a strong academic credential for both education and research. The proposed project is carefully designed to exploit the strengths of IIT's research environment and maximize opportunities for student hands-on research experiences. Successful completion of the proposed studies will have a substantial positive impact on IIT's biomedical research capacity.
Expression of the tumor suppressor Bax can be silenced due to frameshift mutation in microsatellite unstable colon cancer leading to chemoresistance. However, an alternative functional Bax isoform, Bax?2 can be salvaged in these 'Bax-negative' cells. In this proposal, we will study the molecular mechanism and therapeutic potential of Bax?2, and provide enriched hands-on opportunities for undergraduate and graduate students to participate in biological research at the Illinois Institute of Technology.
| Yao, Qi; Zhang, Huaiyuan; Zhao, Yu et al. (2018) The C-terminus of Ubl4A is critical for pro-death activity and association with the Arp2/3 complex. Biochem Biophys Res Commun 503:3192-3197 |
| Mañas, Adriana; Chen, Wenjing; Nelson, Adam et al. (2018) Bax?2 sensitizes colorectal cancer cells to proteasome inhibitor-induced cell death. Biochem Biophys Res Commun 496:18-24 |
| Mañas, Adriana; Wang, Sheng; Nelson, Adam et al. (2017) The functional domains for Bax?2 aggregate-mediated caspase 8-dependent cell death. Exp Cell Res 359:342-355 |
